je.st
news
Tag: announces fourthquarter
CSX Corporation Announces Dates For Earnings Release and Fourth-Quarter Earnings Call
2015-01-05 20:22:11| Railroads - Topix.net
Those interested in participating via teleconference may dial 1-888-327-6279 and ask for the CSX earnings call. Callers outside the U.S. dial 1-773-756-0199.
Tags: call
release
corporation
dates
Windstream Announces Fourth-Quarter, Full-Year 2014 Earnings Call
2015-01-03 17:19:37| Grocery - Topix.net
Windstream will hold a conference call at 7:30 a.m. CST on Feb. 24 to review the company's fourth-quarter and full-year 2014 earnings results. A replay of the call will be available beginning at 10:30 a.m. CST on Feb. 24 and ending at midnight on March 3. The replay can be accessed by dialing 1-855-859-2056, conference ID 60178219.
Tags: call
earnings
announces
fourthquarter earnings
Merck Announces Fourth-Quarter 2014 Dividend
2014-07-23 18:15:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.44 per share of the companys common stock for the fourth quarter of 2014. Payment will be made on October 7, 2014, to stockholders of record at the close of business on September 15, 2014. About Merck Language: English Contact: MerckMedia:Lainie Keller, 908-423-4187orInvestors:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: announces
dividend
merck
announces fourthquarter
LG Electronics Mobile Communications announces improved fourth-quarter 2013 financial results 2013
2014-02-11 07:44:42| Electronics - Topix.net
The LG Mobile Communications Company announced consolidated revenues shipping 13.2 million Smartphones during the fourth quarter of 2013, recording the highest quarterly sales in its history.
Tags: results
mobile
electronics
financial
Merck Announces Fourth-Quarter and Full-Year 2013 Financial Results
2014-02-05 13:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Fourth-Quarter 2013 Non-GAAP EPS Increased by 6 Percent Over Prior Year to $0.88, Excluding Certain Items; GAAP EPS Decreased by 13 Percent to $0.26. Full-Year 2013 Non-GAAP EPS of $3.49, Excluding Certain Items; GAAP EPS of $1.47. Fourth-Quarter 2013 Worldwide Sales Were $11.3 Billion, a Decrease of 4 Percent Reflecting Unfavorable Impact of Patent Expiries and a 3 Percent Negative Impact from Foreign Exchange. Full-Year 2013 Worldwide Sales Were $44.0 Billion, a Decrease of 7 Percent Reflecting Unfavorable Impact of Patent Expiries and a 2 Percent Negative Impact from Foreign Exchange. Strong Full-Year Sales Growth for GARDASIL, REMICADE, SIMPONI, ISENTRESS, ZOSTAVAX and the Diabetes Franchise. Returned $11 Billion to Shareholders in 2013 Through Dividends and Share Repurchases. Accelerated Development Program for MK-3475, Including Announcement of Four Collaborations to Evaluate Novel Combination Regimens, Initiation of a Phase I Study in 20 New Cancer Types and Rolling Submission of a BLA to the FDA. 2014 Full-Year Non-GAAP EPS Target of $3.35 to $3.53, Excluding Certain Items; GAAP EPS Range of $2.15 to $2.47. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2013. Language: English Contact: MerckMedia:Kelley Dougherty, 908- 423-4291Steve Cragle, 908-423-3461orInvestors:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck